Search results
Results From The WOW.Com Content Network
Sorafenib is a protein kinase inhibitor with activity against many protein kinases, including VEGFR, PDGFR and RAF kinases. [4] [5] Of the RAF kinases, sorafenib is more selective for c-Raf than B-RAF. [6] (See BRAF (gene)#Sorafenib for details the drug's interaction with B-Raf.) Sorafenib treatment induces autophagy, [7] which
The following antidepressants are available both with a prescription and over-the-counter: Ademetionine [S-Adenosyl-L-methionine (SAMe)] (Heptral, Transmetil, Samyl) – cofactor in monoamine neurotransmitter biosynthesis; Hypericum perforatum [St. John's Wort (SJW)] (Jarsin, Kira, Movina) – TRPC6 activator, and various other actions
Over the counter Non-prescription Age restriction Cost Awareness Notes Afghanistan: Asia: Import only [2] Albania: Europe: None [3] €15,60 (UPA) €4,50 (LNG) 66-75% [4] [5] "Currently, Postinor-2 (LNG) is the only EC brand available in Albania as there is a stock out of NorLevo in the country for unknown reasons." [6] Algeria: Africa (LNG ...
AZ2171 , a multi-targeted tyrosine kinase inhibitor has been shown to have anti-edema effects by reducing the permeability and aiding in vascular normalization. [ 4 ] A 2014 Cochrane Systematic Review studied the effectiveness of ranibizumab and pegaptanib , on patients who have macular edema caused by central retinal vein occlusion . [ 5 ]
Donafenib, sold under the brand name Zepsun, is a pharmaceutical drug for the treatment of cancer.. In China, donafenib is approved for the treatment of unresectable hepatocellular carcinoma in patients who have not previously received systemic treatment.
For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...
Originally available only by prescription, it was approved by the FDA for over-the-counter sale in February 2007. [32] In May 2010, the U.S. Food and Drug Administration (FDA) approved a revised label for Xenical to include new safety information about rare cases of severe liver injury that have been reported with the use of this medication. [33]
Pazopanib, sold under the brand name Votrient, is an anti-cancer medication marketed worldwide by Novartis.It is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis.